Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A comprehensive profile of recurrent glioblastoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Intestinal necrosis in young patient due to arterial tumour embolism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Komplet remission af højmalignt lymfom i ventriklen efter eradikation af Helicobacter pylori

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  • M E Law
  • P E Corsino
  • S C Jahn
  • B J Davis
  • S Chen
  • B Patel
  • K Pham
  • Jingquan Lu
  • B Sheppard
  • P Nørgaard
  • Jing Hong
  • P Higgins
  • J-S Kim
  • H Luesch
  • B K Law
Vis graf over relationer
Aggressive cancers often express E-cadherin in cytoplasmic vesicles rather than on the plasma membrane and this may contribute to the invasive phenotype of these tumors. Therapeutic strategies are not currently available that restore the anti-invasive function of E-cadherin in cancers. MDA-MB-231 cells are a frequently used model of invasive triple-negative breast cancer, and these cells express low levels of E-cadherin that is mislocalized to cytoplasmic vesicles. MDA-MB-231 cell lines stably expressing wild-type E-cadherin or E-cadherin fused to glutathione S-transferase or green fluorescent protein were used as experimental systems to probe the mechanisms responsible for cytoplasmic E-cadherin localization in invasive cancers. Although E-cadherin expression partly reduced cell invasion in vitro, E-cadherin was largely localized to the cytoplasm and did not block the invasiveness of the corresponding orthotopic xenograft tumors. Further studies indicated that the glucocorticoid dexamethasone and the highly potent class I histone deacetylase (HDAC) inhibitor largazole cooperated to induce E-cadherin localization to the plasma membrane in triple-negative breast cancers, and to suppress cellular invasion in vitro. Dexamethasone blocked the production of the cleaved form of the CDCP1 (that is, CUB domain-containing protein 1) protein (cCDCP1) previously implicated in the pro-invasive activities of CDCP1 by upregulating the serine protease inhibitor plasminogen activator inhibitor-1. E-cadherin preferentially associated with cCDCP1 compared with the full-length form. In contrast, largazole did not influence CDCP1 cleavage, but increased the association of E-cadherin with γ-catenin. This effect on E-cadherin/γ-catenin complexes was shared with the nonisoform selective HDAC inhibitors trichostatin A (TSA) and vorinostat (suberoylanilide hydroxamic acid, SAHA), although largazole upregulated endogenous E-cadherin levels more strongly than TSA. These results demonstrate that glucocorticoids and HDAC inhibitors, both of which are currently in clinical use, cooperate to suppress the invasiveness of breast cancer cells through novel, complementary mechanisms that converge on E-cadherin.Oncogene advance online publication, 30 April 2012; doi:10.1038/onc.2012.138.
OriginalsprogEngelsk
TidsskriftOncogene
Vol/bind32
Udgave nummer10
Sider (fra-til)1316-29
Antal sider14
ISSN0950-9232
DOI
StatusUdgivet - 2013

ID: 36840566